Search Within

Anas Younes

  1. "2014"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (11)
Groups
  1. Center for Hematologic Malignancies (30)
  2. Department of Medicine (30)
  3. Executive Committee, Center for Hematologic Malignancies (30)
  4. Hematologic Malignancies, Division of (30)
  5. Lymphoma (30)
  6. GSK Faculty (9)

More Groups

People
  1. Andrew Zelenetz (7)
  2. Craig Moskowitz (6)
  3. Maria Palomba (6)
  4. Ahmet Dogan (5)
  5. Andrew Intlekofer (5)
  6. Julie Feldstein (5)

More People

Years
  1. 2014 (30)
Publications
  1. Blood (10)
  2. Cancer Research (3)
  3. British Journal of Haematology (2)
  4. Journal of Clinical Oncology (2)
  5. Annals of Hematology (1)
  6. Biology of Blood and Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. American Association for Cancer Research (3)
  3. Elsevier Inc. (3)
  4. American Society of Clinical Oncology (2)
  5. John Wiley & Sons (2)
  6. Nature Publishing Group (2)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diffuse large B cell lymphoma: Using pathologic and molecular biomarkers to define subgroups for novel therapy
    Journal Article

    Carbone, A.; Gloghini, A.; Kwong, Y. L.; Younes, A.
    Annals of Hematology (2014)

    Fulltext@MSK | Save
  • Role of CD30 targeting in malignant lymphoma
    Journal Article

    Kumar, A.; Younes, A.
    Current Treatment Options in Oncology (2014)

    Fulltext@MSK | Save
  • From empiric to mechanism-based therapy for peripheral T cell lymphoma
    Journal Article

    Intlekofer, A. M.; Younes, A.
    International Journal of Hematology (2014)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma: Changing treatment paradigms - The Dunleavy/Wilson article reviewed [Appropriate management of molecular subtypes of diffuse large B-cell lymphoma]
    Journal Article

    Batlevi, C. L.; Younes, A.
    Oncology (Norwalk) (2014)

    Fulltext@MSK | Save
  • Genetic landscape of diffuse large B-cell lymphoma (DLBCL) using a novel diagnostic targeted sequencing platform
    Meeting Abstract

    Setoodeh, R.; Teruya-Feldstein, J.; Seshan, V.; Levine, R.; Zelenetz, A.; Palomba, L.; Moskowitz, C.; Van Den Brink, M.; Knapp, K.; Copeland, A.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Genetic landscape of diffuse large B-cell lymphoma (DLBCL) using a novel diagnostic targeted sequencing platform
    Meeting Abstract

    Setoodeh, I.; Teruya-Feldstein, J.; Seshan, V.; Levine, R.; Zelenetz, A.; Palomba, L.; Moskowitz, C.; Van Den Brink, M.; Knapp, K.; Copeland, A.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Reduced-intensity conditioning and allogeneic stem cell transplantation for relapsed/refractory Hodgkin lymphoma in the brentuximab vedotin era
    Meeting Abstract

    Anderlini, P.; Saliba, R.; Ledesma, C.; Chancoco, C. M.; Alexander, T. R.; Alousi, A. M.; Hosing, C.; Khouri, I. F.; Nieto, Y.; Popat, U. R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin's lymphoma
    Journal Article

    Subbiah, V.; Brown, R. E.; McGuire, M. F.; Buryanek, J.; Janku, F.; Younes, A.; Hong, D.
    Oncotarget (2014)

    Fulltext@MSK | Save
  • Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma
    Journal Article

    Fanale, M.; Assouline, S.; Kuruvilla, J.; Solal-Céligny, P.; Heo, D. S.; Verhoef, G.; Corradini, P.; Abramson, J. S.; Offner, F.; Engert, A.; more...
    British Journal of Haematology (2014)

    Fulltext@MSK | Save
  • Brentuximab vedotin for the treatment of patients with hodgkin lymphoma
    Journal Article

    Younes, A.
    Hematology/Oncology Clinics of North America (2014)

    Fulltext@MSK | Save